Published in J Womens Health (Larchmt) on July 20, 2012
Clinical application of DNA ploidy to cervical cancer screening: A review. World J Clin Oncol (2014) 0.93
Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study. Int J Cancer (2015) 0.84
Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age. J Infect Dis (2014) 0.84
Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a Korean Gynecologic Oncology Group study. Br J Cancer (2013) 0.83
Results of cytology and high-risk human papillomavirus testing in females with cervical adenocarcinoma in situ. Oncol Lett (2013) 0.81
Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate. Br J Cancer (2014) 0.81
Human papillomavirus prevalence in a population of women living in Port-au-Prince and Leogane, Haiti. PLoS One (2013) 0.80
Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix? Int J Cancer (2016) 0.79
Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma. Front Oncol (2014) 0.78
Human Papillomavirus Laboratory Testing: the Changing Paradigm. Clin Microbiol Rev (2016) 0.76
Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer. Hum Vaccin Immunother (2015) 0.76
Cervical Cancer Histology, Staging and Survival before and after Implementation of Organised Cervical Screening Programme in Poland. PLoS One (2016) 0.75
Practical issues related to uterine pathology: in situ and invasive cervical glandular lesions and their benign mimics: emphasis on cytology-histology correlation and interpretive pitfalls. Mod Pathol (2016) 0.75
Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013. Cancer Med (2017) 0.75
Improving the Utilization of Human Papillomavirus and Cervical Cytology Co-testing for Cervical Cancer Screening in an Obstetrics and Gynecology Resident Clinic. Hawaii J Med Public Health (2015) 0.75
Trends in Cervical Cancer Among Delivery-Related Discharges and its Impact on Maternal-Infant Birth Outcomes (United States, 1998-2009). Open Nurs J (2015) 0.75
Addressing multilevel barriers to cervical cancer screening in Korean American women: A randomized trial of a community-based intervention. Cancer (2016) 0.75
A birth cohort analysis of the incidence of adenocarcinoma of the uterine cervix in the USA. Eur J Cancer Prev (2015) 0.75
Using qualitative methods to develop a contextually tailored instrument: Lessons learned. Asia Pac J Oncol Nurs (2016) 0.75
The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship. Am J Surg Pathol (2016) 0.75
Intimate Partner Violence and Barriers to Cervical Cancer Screening: A Gynecologic Oncology Fellow Research Network Study. J Low Genit Tract Dis (2016) 0.75
The impact of examined lymph node count on survival in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Cancer Manag Res (2017) 0.75
Trends in the Incidence of Cervical Cancer in Jordan, 2000-2013. J Oncol (2017) 0.75
Association of HLA-DRB1, HLA-DQB1 Polymorphisms with HPV 16 E6 Variants among Young Cervical Cancer Patients in China. J Cancer (2017) 0.75
Surveillance of high-grade cervical cancer precursors (CIN III/AIS) in four population-based cancer registries, United States, 2009-2012. Prev Med (2017) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol (2010) 9.86
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol (2011) 5.59
HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA (2000) 4.62
The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study. Gynecol Oncol (2000) 2.76
Trends in contraceptive use in the United States: 1982-1995. Fam Plann Perspect (1998) 2.70
Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer (2004) 2.46
FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol (1994) 2.10
International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer (2000) 1.79
Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes Control (2009) 1.65
Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol (2007) 1.60
Adherence to cervical cancer screening guidelines for U.S. women aged 25-64: data from the 2005 Health Information National Trends Survey (HINTS). J Womens Health (Larchmt) (2009) 1.52
Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer (2007) 1.48
Trends in cervical and breast cancer screening practices among women in rural and urban areas of the United States. J Public Health Manag Pract (2009) 1.44
Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival. Cancer (2005) 1.35
Screening for cervical cancer: recommendations and rationale. Am J Nurs (2003) 1.25
Etiologic heterogeneity for cervical carcinoma by histopathologic type, using comparative age-period-cohort models. Cancer Epidemiol Biomarkers Prev (2009) 1.18
Cervical cancer incidence among 6 asian ethnic groups in the United States, 1996 through 2004. Cancer (2010) 1.18
Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecol Oncol (2009) 1.16
The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995. Acta Obstet Gynecol Scand (1999) 1.13
Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs. Cancer (2008) 1.02
Prevalence and trends in oral contraceptive use in premenopausal females ages 12-54 years, United States, 1971-80. Am J Public Health (1985) 0.99
The challenge of eliminating cervical cancer in the United States: a story of politics, prudishness, and prevention. Women Health (2009) 0.99
Timeliness and follow-up patterns of cervical cancer detection in a cohort of medically underserved California women. Cancer Causes Control (2009) 0.99
The impact of human papillomavirus vaccination on cervical cancer prevention efforts. Gynecol Oncol (2009) 0.95
How might HPV testing be integrated into cervical screening? Lancet Oncol (2011) 0.82
Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer (2006) 5.87
Use of SEER-Medicare data for measuring cancer surgery. Med Care (2002) 4.27
Dissemination of Evidence-based Practice Center reports. Ann Intern Med (2005) 2.05
Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med (2015) 1.63
Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction. Cancer (2010) 1.53
Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment. Gynecol Oncol (2009) 1.12
Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it? Gynecol Oncol (2008) 1.09
Comparison of Medicare claims versus physician adjudication for identifying stroke outcomes in the Women's Health Initiative. Stroke (2014) 1.05
Quality of life in a prospective cohort of elderly women with and without cancer. Cancer (2009) 1.02
Contralateral prophylactic mastectomy for patients with unilateral breast cancer. Expert Rev Anticancer Ther (2007) 1.00
Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol (2008) 0.98
Pap testing and sexual activity among young women in the United States. Obstet Gynecol (2009) 0.95
Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis. Gynecol Oncol (2007) 0.94
Prevalence of incontinence by race and ethnicity of older people admitted to nursing homes. J Am Med Dir Assoc (2013) 0.93
Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening. Obstet Gynecol (2006) 0.91
Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness. Obstet Gynecol (2010) 0.89
Angiotensin converting enzyme inhibitors may be protective against cardiac complications following anthracycline chemotherapy. Breast Cancer Res Treat (2010) 0.87
Management of platinum-sensitive recurrent ovarian cancer: a cost-effectiveness analysis. Gynecol Oncol (2007) 0.85
Liquid-based Papanicolaou smears without a transformation zone component: should clinicians worry? Obstet Gynecol (2002) 0.84
Diabetes, diabetes treatment and breast cancer prognosis. Breast Cancer Res Treat (2014) 0.84
Chapter 10: deciding whether to complement a systematic review of medical tests with decision modeling. J Gen Intern Med (2012) 0.84
The association of hip circumference with incident hip fracture in a cohort of postmenopausal women: the Iowa Women's Health Study. Ann Epidemiol (2008) 0.79
Variation in diabetes care quality among medicare advantage plans: understanding the role of case mix. Am J Med Qual (2011) 0.77
Prevalence of pressure ulcers by race and ethnicity for older adults admitted to nursing homes. J Gerontol Nurs (2013) 0.76
Institutional care at the end of life. Med Care (2007) 0.75
Behavioral and community correlates of adolescent pregnancy and Chlamydia rates in rural counties in Minnesota. J Community Health (2015) 0.75
Single Health System Adherence to 2012 Cervical Cancer Screening Guidelines at Extremes of Age and Posthysterectomy. Obstet Gynecol (2017) 0.75
Re: Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst (2010) 0.75
Effect of daily migraine prevention on health care utilisation in an insured patient population. J Headache Pain (2007) 0.75
Predictors of Pertussis Polymerase Chain Reaction Positive Results in Minnesota, 2005-2009. Pediatr Infect Dis J (2015) 0.75
Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia. Obstet Gynecol (2017) 0.75
Adding decision models to systematic reviews: informing a framework for deciding when and how to do so. Value Health (2013) 0.75